AAAAAA

   
Results: 1-25 | 26-50 | 51-67
Results: 1-25/67
Cholesterol in children: Screening and treatment, rationales and strategies
Authors: de Ferranti, S Rifai, N
Citation: S. De Ferranti et N. Rifai, Cholesterol in children: Screening and treatment, rationales and strategies, J CLIN LIG, 24(1), 2001, pp. 33-42
The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin and mitoxantrone-induced cardiotoxicity
Authors: Herman, EH Zhang, J Rifai, N Lipshultz, SE Hasinoff, BB Chadwick, DP Knapton, A Chai, J Ferrans, VJ
Citation: Eh. Herman et al., The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin and mitoxantrone-induced cardiotoxicity, CANC CHEMOT, 48(4), 2001, pp. 297-304
Plasma leptin concentrations and four-year weight gain among US men
Authors: Chu, NF Spiegelman, D Yu, J Rifai, N Hotamisligil, GS Rimm, EB
Citation: Nf. Chu et al., Plasma leptin concentrations and four-year weight gain among US men, INT J OBES, 25(3), 2001, pp. 346-353
Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men
Authors: Chu, NF Stampfer, MJ Spiegelman, D Rifai, N Hotamisligil, GS Rimm, EB
Citation: Nf. Chu et al., Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men, INT J OBES, 25(1), 2001, pp. 106-114
Blood pressure and inflammation in apparently healthy men
Authors: Chae, CU Lee, RT Rifai, N Ridker, PM
Citation: Cu. Chae et al., Blood pressure and inflammation in apparently healthy men, HYPERTENSIO, 38(3), 2001, pp. 399-403
Simultaneous measurement of plasma ropivacaine and bupivacaine concentrations by HPLC with UV detection
Authors: Rifai, N Hsin, O Hope, T Sakamoto, M
Citation: N. Rifai et al., Simultaneous measurement of plasma ropivacaine and bupivacaine concentrations by HPLC with UV detection, THER DRUG M, 23(2), 2001, pp. 182-186
Fasting plasma homocysteine levels in the insulin resistance syndrome - The Framingham Offspring Study
Authors: Meigs, JB Jacques, PF Selhub, J Singer, DE Nathan, DM Rifai, N D'Agostino, RB Wilson, PWF
Citation: Jb. Meigs et al., Fasting plasma homocysteine levels in the insulin resistance syndrome - The Framingham Offspring Study, DIABET CARE, 24(8), 2001, pp. 1403-1410
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
Authors: Pradhan, AD Manson, JE Rifai, N Buring, JE Ridker, PM
Citation: Ad. Pradhan et al., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, J AM MED A, 286(3), 2001, pp. 327-334
Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction - Results from a randomized trial
Authors: Morrow, DA Cannon, CP Rifai, N Frey, MJ Vicari, R Lakkis, N Robertson, DH Hille, DA DeLucca, PT DiBattiste, PM Demopoulos, LA Weintraub, WS Braunwald, E
Citation: Da. Morrow et al., Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction - Results from a randomized trial, J AM MED A, 286(19), 2001, pp. 2405-2412
Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
Authors: Albert, MA Danielson, E Rifai, N Ridker, PM
Citation: Ma. Albert et al., Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study, J AM MED A, 286(1), 2001, pp. 64-70
Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
Authors: Ridker, PM Stampfer, MJ Rifai, N
Citation: Pm. Ridker et al., Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease, J AM MED A, 285(19), 2001, pp. 2481-2485
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
Authors: Ridker, PM Rifai, N Clearfield, M Downs, JR Weis, SE Miles, JS Gotto, AM
Citation: Pm. Ridker et al., Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events, N ENG J MED, 344(26), 2001, pp. 1959-1965
Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women
Authors: Herrington, DM Brosnihan, KB Pusser, BE Seely, EW Ridker, PM Rifai, N MacLean, DB
Citation: Dm. Herrington et al., Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women, J CLIN END, 86(9), 2001, pp. 4216-4222
Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: A randomized controlled trial
Authors: Sesmilo, G Biller, BMK Llevadot, J Hayden, D Hanson, G Rifai, N Klibanski, A
Citation: G. Sesmilo et al., Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: A randomized controlled trial, J CLIN END, 86(4), 2001, pp. 1518-1524
Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men
Authors: Chu, NF Spiegelman, D Hotamisligil, GS Rifai, N Stampfer, M Rimm, EB
Citation: Nf. Chu et al., Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men, ATHEROSCLER, 157(2), 2001, pp. 495-503
Evolution of methods for measurement of HDL-cholesterol: From ultracentrifugation to homogeneous assays
Authors: Warnick, GR Nauck, M Rifai, N
Citation: Gr. Warnick et al., Evolution of methods for measurement of HDL-cholesterol: From ultracentrifugation to homogeneous assays, CLIN CHEM, 47(9), 2001, pp. 1579-1596
Evaluation of nine automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Part 2 (vol 47,pg 418 2001)
Authors: Roberts, WL Moulton, L Law, TC Farrow, G Cooper-Anderson, M Savory, J Rifai, N
Citation: Wl. Roberts et al., Evaluation of nine automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Part 2 (vol 47,pg 418 2001), CLIN CHEM, 47(5), 2001, pp. 980-980
High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease
Authors: Rifai, N Ridker, PM
Citation: N. Rifai et Pm. Ridker, High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease, CLIN CHEM, 47(3), 2001, pp. 403-411
Evaluation of nine automated high-sensitivity c-reactive protein methods: Implications for clinical and epidemiological applications. Part 2
Authors: Roberts, WL Moulton, L Law, TC Farrow, G Cooper-Anderson, M Savory, J Rifai, N
Citation: Wl. Roberts et al., Evaluation of nine automated high-sensitivity c-reactive protein methods: Implications for clinical and epidemiological applications. Part 2, CLIN CHEM, 47(3), 2001, pp. 418-425
Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects
Authors: Meier-Ewert, HK Ridker, PM Rifai, N Price, N Dinges, DF Mullington, JM
Citation: Hk. Meier-ewert et al., Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects, CLIN CHEM, 47(3), 2001, pp. 426-430
Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults
Authors: Ockene, IS Matthews, CE Rifai, N Ridker, PM Reed, G Stanek, E
Citation: Is. Ockene et al., Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults, CLIN CHEM, 47(3), 2001, pp. 444-450
Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening
Authors: Rifai, N Ridker, PM
Citation: N. Rifai et Pm. Ridker, Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening, CLIN CHEM, 47(1), 2001, pp. 28-30
Gender differences in exercise-induced changes in sex hormone levels and lipid peroxidation in athletes participating in the Hawaii Ironman triathlonGinsburg-gender and exercise-induced lipid peroxidation
Authors: Ginsburg, GS O'toole, M Rimm, E Douglas, PS Rifai, N
Citation: Gs. Ginsburg et al., Gender differences in exercise-induced changes in sex hormone levels and lipid peroxidation in athletes participating in the Hawaii Ironman triathlonGinsburg-gender and exercise-induced lipid peroxidation, CLIN CHIM A, 305(1-2), 2001, pp. 131-139
Rapid reduction in C-reactive protein with cerivastatin among 785 patientswith primary hypercholesterolemia
Authors: Ridker, PM Rifai, N Lowenthal, SP
Citation: Pm. Ridker et al., Rapid reduction in C-reactive protein with cerivastatin among 785 patientswith primary hypercholesterolemia, CIRCULATION, 103(9), 2001, pp. 1191-1193
Soluble P-selectin and the risk of future cardiovascular events
Authors: Ridker, PM Buring, JE Rifai, N
Citation: Pm. Ridker et al., Soluble P-selectin and the risk of future cardiovascular events, CIRCULATION, 103(4), 2001, pp. 491-495
Risultati: 1-25 | 26-50 | 51-67